ACVRL1 and systemic sclerosis: Authors also demonstrated that the Endoglin/ALK1 pathway can regulate the ET-1 gene expression in dermal fibroblasts, supporting the pro-fibrotic contribution of Endoglin/ALK1 axis in SSc (48).